Astrana HealthASTH +1.35%87 PB Ratio is 2.70 as of Jun. 26, 2026, which is 11% below its 10-year median of 3.04. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Astrana Health ranks worse than 63.18% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Astrana Health's share price is $44.065. Astrana Health's Book Value per Share for the quarter that ended in Mar. 2026 was $16.35. Hence, Astrana Health's PB Ratio of today is 2.70.
Warning Sign:
Astrana Health Inc stock PB Ratio (=2.66) is close to 1-year high of 2.66.
The historical rank and industry rank for Astrana Health's PB Ratio or its related term are showing as below:
ASTH'
s PB Ratio Range Over the Past 10 Years
Min: 1.18 Med: 3.04 Max: 12.44
Current: 2.7
During the past 13 years, Astrana Health's highest PB Ratio was 12.44. The lowest was 1.18. And the median was 3.04.
ASTH's PB Ratio is ranked worse than 63.18% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs ASTH: 2.70
During the past 12 months, Astrana Health's average Book Value Per Share Growth Rate was 7.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 11.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 14.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Astrana Health was 29.70% per year. The lowest was -104.90% per year. And the median was -16.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Astrana Health PB Ratio Related Terms
Astrana Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Astrana Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Astrana Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Astrana Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Astrana Health's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Astrana Health (ASTH) has a PB Ratio of 2.70 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Astrana Health and its competitors. This is 11% below median its historical median of 3.04. Over the past decade, Astrana Health's PB Ratio has ranged from 1.18 to 12.44. According to the industry distribution chart, Astrana Health ranks #386 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 63.2%.
Is Astrana Health's PB Ratio too high?
Astrana Health's current PB Ratio of 2.70 is 11% below median its 10-year median of 3.04. Over the past 10 years, this metric has ranged from a low of 1.18 to a high of 12.44. The Healthcare Providers & Services industry median PB Ratio is 1.98. Astrana Health's value of 2.70 is 36.4% above this industry median. Based on the distribution chart, Astrana Health ranks #386 out of 611 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's PB Ratio compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #386 out of 611 companies for PB Ratio. This places Astrana Health in the lower half of its industry. The industry median PB Ratio is 1.98. Astrana Health's value of 2.70 is 36.4% above this benchmark. Historically, Astrana Health's own PB Ratio has ranged from 1.18 to 12.44 over the past decade. While the company's 10-year median is 3.04 vs. the industry median of 1.98, Astrana Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current PB Ratio of 2.70 is 36.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current PB Ratio is 2.70, which is 11% below median its own 10-year median of 3.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $44.07 — trading 46.5% below its estimated fair value. The current PB Ratio is 2.70, which is 11% below median its 10-year median of 3.04 and 36.4% above the Healthcare Providers & Services industry median of 1.98. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Astrana Health (ASTH), the current PB Ratio is 2.70 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $44.07 is trading 46.5% below its estimated GF Value™ of $82.34.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
PB Ratio: 2.70 (11% below median its 10-year median of 3.04)
GF Value™: $82.34 vs. price of $44.07 (46.5% below fair value)
Industry Position: 36.4% above the Healthcare Providers & Services median (#386 of 611)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score
Get the complete analysis for ASTH
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
